Medication adherence in schizophrenia: A comparison between outpatients and relapse cases

East Asian Archives of Psychiatry

Volumn 24, Issue 2, 2014, Pages 68-74

  Razali, Salleh Mohd ^a   Yusoff, Mzam ^b  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b General Hospital Kota Bharu   (Malaysia)

Author keywords

Patient compliance; Psychopathology; Schizophrenia; Social support

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HIGH SCHOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE RATING SCALE; MEDICATION COMPLIANCE; OUTPATIENT; PATIENT COMPLIANCE; PRESCRIPTION; RATING SCALE; RELAPSE; SCHIZOPHRENIA; SOCIAL SUPPORT; COMPREHENSION; HOSPITALIZATION; PSYCHOLOGY; RECURRENT DISEASE; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADULT; COMPREHENSION; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; OUTPATIENTS; RECURRENCE; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL SUPPORT; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84904151219     PISSN: 20789947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hayness BR, Sackett DL. Compliance with therapeutic regimen. Baltimore: John Hopkins University Press; 1976.
2. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-9.
3. Corrigan PW, Liberman RP, Engel JD. From non-compliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry 1990;41:1203-11.
4. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998;49:196-201. (Pubitemid 28071427)
5. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(Suppl 4):1-46.
6. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;21:419-29.
7. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653-64.
8. Razali SM. Prevention of relapse and interventions for enhancing medication adherence in schizophrenia: an East Asian perspective. Asia Pac Psychiatry 2010;2:68-76.
9. Cooper C, Bebbington P, King M, Brugha T, Meltzer H, Bhugra D, et al. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatr Scand 2007;116:47-53. (Pubitemid 46889774)
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision (DSM IV-TR). Washington DC: APA; 2000.
11. Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res 2008;100:53-9.
12. McEvoy JP, Freter S, Everett G, Geller JL, Appelbaum P, Apperson LJ, et al. Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis 1989;177:48-51. (Pubitemid 19043859)
13. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support (MSPSS). J Pers Assess 1988;52:30-41.
14. Ng CG, Amer Siddiq AN, Aida SA, Zainal NZ, Koh OH. Validation of the Malay version of the Multidimensional Scale of Perceived Social Support (MSPSS-M) among a group of medical students in Faculty of Medicine, University Malaya. Asian J Psychiatry 2010;3:3-6.
15. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 1985;326(Suppl):7-37.
16. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909. (Pubitemid 35231730)
17. Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, et al. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res 2012;134:226-31.
18. Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 2003;33:1149-60. (Pubitemid 37265204)
19. Razali SM, Khan UA, Hasanah CI. Belief in supernatural causes of mental illness among Malay patients: impact on treatment. Acta Psychiatr Scand 1996;94:229-33. (Pubitemid 26344629)
20. Lee S, Chiu MY, Tsang A, Chui H, Kleinman R. Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Hong Kong. Soc Sci Med 2006;62:1685-96. (Pubitemid 43243265)
21. Razali SM, Najib MA. Help-seeking behaviour among Malay psychiatric patients. Int J Soc Psychiatry 2000;46:281-9. (Pubitemid 32094279)
22. Offord S, Lin J, Mirski D, Wong B. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia. Adv Ther 2013;30:286-97.
23. Caseiro O, Pérez-Iglesias R, Mata I, Martínez-Garcia O, Pelayo-Terán JM, Tabares-Seisdedos R, et al. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. J Psychiatr Res 2012;46:1099-105.
24. Schennach R, Obermeier M, Meyer S, Jager M, Schmauss M, Laux G, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv 2012;63:87-90.
25. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-51. (Pubitemid 27485972)
26. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1990;2:19-33.
27. Ng CG, Loh HS, Yee HA, Zainal NZ. The prevalence and associated factors of psychiatric early readmission in a teaching hospital, Malaysia. Malays J Psychiatry 2012;21:1-3.
28. San L, Bernardo M, Gómez A, Peña M. Factors associated with relapse in patients with schizophrenia. Int J Psychiatry Clin Pract 2013;17:2-9.
29. Draman S, Ismail S, Merchant M, Yusof H, Husin T, Singh SI. A study on risk factors of repeated admissions among patients with schizophrenia in Hospital Kota Bharu, Kelantan, Malaysia. Inter Med J 2005;12:185-92. (Pubitemid 41442210)
30. Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, et al. A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 2004;65:211-6.
31. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994;51:826-36. (Pubitemid 24313308)
32. Rocca PB, Marino F, Mongini T, Portaleone F, Bogetto F. Correlation of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia. Compr Psychiatry 2008;49:170-6. (Pubitemid 351163232)
33. Misdrahi D, Petit M, Blanc O, Bayle F, Llorca PM. The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nord J Psychiatry 2012;66:49-54.
34. Tsang HW, Fung KM, Corrigan PW. Psychosocial and sociodemographic correlates of medication compliance among people with schizophrenia. J Behav Ther Exper Psychiatry 2009;40:3-14.
35. Nakano H, Terao T, Iwata N, Hasako R, Nakamura J. Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res 2004;127:65-72. (Pubitemid 38916868)
36. Weiden P, Olfson M, Essock S. Medication non-compliance in schizophrenia: effects on mental health service policy. In: Blackwell B, editor. Treatment compliance and the therapeutic alliance. Brunswick, NJ: Harwood Academic Press; 1997.
37. Marder SR, Mebane A, ChienCP. A comparison of patients who refused and consent to neuroleptic treatment. Am J Psychiatry 1983;140:470-2. (Pubitemid 13163135)
38. Hoge SK, Appelbaum PS, Lawlor T, Beck JC, Litman R, Greer A, et al. A prospective, multi-centre study of patients' refusal of antipsychotic medication. Arch Gen Psychiatry 1990;47:949-56. (Pubitemid 20348483)
39. Hayness RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;(2):CD000011.
40. Razali SM, Yahya H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 1995;91:331-5.